MedPath
HSA Approval

Budesonide Nasal spray suspension 64mcg

SIN14029P

Budesonide Nasal spray suspension 64mcg

Budesonide Nasal spray suspension 64mcg

October 11, 2011

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SPRAY, SUSPENSION

NASAL

Medical Information

R01AD05

budesonide

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Laboratorio Aldo-Union S.L.

Active Ingredients

Budesonide micronized

64.0 mcg/dose

Budesonide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Budesonide Nasal spray suspension 64mcg - HSA Approval | MedPath